Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.

Perkons NR, Kiefer RM, Noji MC, Pourfathi M, Ackerman D, Siddiqui S, Tischfield D, Profka E, Johnson O, Pickup S, Mancuso A, Pantel A, Denburg MR, Nadolski GJ, Hunt SJ, Furth EE, Kadlecek S, Gade TPF.

Hepatology. 2019 Sep 25. doi: 10.1002/hep.30970. [Epub ahead of print]

PMID:
31553806
2.

Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies.

Tischfield DJ, Ackerman D, Noji M, Chen JX, Johnson O, Perkons NR, Nadolski GJ, Hunt SJ, Soulen MC, Furth EE, Gade TP.

Sci Rep. 2019 Jul 22;9(1):10546. doi: 10.1038/s41598-019-47104-9.

3.

Management of giant cell hepatitis associated with chronic lymphocytic leukemia - a case series and review of the literature.

Rhodes JM, Schuster SJ, Furth EE, Kennard K, Nasta SD, Svoboda J, Porter DL, Mato AR.

Cancer Biol Ther. 2019;20(8):1136-1140. doi: 10.1080/15384047.2019.1598763. Epub 2019 May 15.

PMID:
31091174
4.

Promotion of growth factor signaling as a critical function of β-catenin during HCC progression.

Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer KE, Furth EE, Viatour P.

Nat Commun. 2019 Apr 23;10(1):1909. doi: 10.1038/s41467-019-09780-z.

5.

The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance.

Mahmud N, Stashek K, Katona BW, Tondon R, Shroff SG, Roses R, Furth EE, Metz DC.

Ann Gastroenterol. 2019 Jan-Feb;32(1):67-72. doi: 10.20524/aog.2018.0325. Epub 2018 Nov 8.

6.

EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D, Stanger BZ.

Dev Cell. 2018 Jun 18;45(6):681-695.e4. doi: 10.1016/j.devcel.2018.05.027.

7.

Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.

Ecker BL, Hoteit MA, Forde KA, Hsu CC, Reddy KR, Furth EE, Siegelman ES, Habibollahi P, Ben-Josef E, Porrett PM, Abt PL, Shaked A, Olthoff KM, Levine MH.

Transplantation. 2018 Apr;102(4):648-655. doi: 10.1097/TP.0000000000002056.

PMID:
29319629
8.

Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.

Habibollahi P, Shamchi SP, Tondon R, Ecker BL, Gade TP, Hunt S, Soulen MC, Furth EE, Levine MH, Nadolski G.

J Vasc Interv Radiol. 2018 Feb;29(2):237-243. doi: 10.1016/j.jvir.2017.09.008. Epub 2017 Dec 6.

PMID:
29221923
9.

The notch pathway is activated in neoplastic progression in esophageal squamous cell carcinoma.

Lubin DJ, Mick R, Shroff SG, Stashek K, Furth EE.

Hum Pathol. 2018 Feb;72:66-70. doi: 10.1016/j.humpath.2017.11.004. Epub 2017 Nov 12.

PMID:
29137934
10.

Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case report.

Windon AL, Tondon R, Singh N, Abu-Gazala S, Porter DL, Russell JE, Cook C, Lander E, Smith G, Olthoff KM, Shaked A, Hoteit M, Furth EE, Serper M.

Am J Transplant. 2018 Mar;18(3):745-749. doi: 10.1111/ajt.14581. Epub 2017 Dec 9.

11.

Extracranial Aneurysms in 2 Patients with Autosomal Recessive Polycystic Kidney Disease.

Elchediak DS, Cahill AM, Furth EE, Kaplan BS, Hartung EA.

Case Rep Nephrol Dial. 2017 May 2;7(2):34-42. doi: 10.1159/000475492. eCollection 2017 May-Aug.

12.

Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.

Kiefer RM, Hunt SJ, Pulido S, Pickup S, Furth EE, Soulen MC, Nadolski GJ, Gade TP.

J Vasc Interv Radiol. 2017 Jul;28(7):1043-1050.e2. doi: 10.1016/j.jvir.2017.03.037. Epub 2017 May 9.

13.

Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.

Gade TPF, Tucker E, Nakazawa MS, Hunt SJ, Wong W, Krock B, Weber CN, Nadolski GJ, Clark TWI, Soulen MC, Furth EE, Winkler JD, Amaravadi RK, Simon MC.

Radiology. 2017 Jun;283(3):702-710. doi: 10.1148/radiol.2017160728. Epub 2017 Mar 2.

14.

Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".

Braxton DR, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette JD, Tondon R, Furth EE.

Hum Pathol. 2017 Apr;62:232-241. doi: 10.1016/j.humpath.2017.02.001. Epub 2017 Feb 21.

PMID:
28232156
15.

CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.

Chao T, Furth EE, Vonderheide RH.

Cancer Immunol Res. 2016 Nov;4(11):968-982. Epub 2016 Oct 13.

16.

Esophageal Lichen Planus: Clinical and Radiographic Findings in Eight Patients.

Rauschecker AM, Levine MS, Whitson MJ, Tondon R, Rubesin SE, Furth EE, Metz DC.

AJR Am J Roentgenol. 2017 Jan;208(1):101-106. doi: 10.2214/AJR.16.16793. Epub 2016 Oct 11.

PMID:
27726411
17.

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

Ecker BL, Taylor L, Zhang PJ, Furth EE, Ginsberg GG, McMillan MT, Datta J, Czerniecki BJ, Roses RE.

PLoS One. 2016 Aug 25;11(8):e0161781. doi: 10.1371/journal.pone.0161781. eCollection 2016.

18.

Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis.

Chauhan A, Sultan LR, Furth EE, Jones LP, Khungar V, Sehgal CM.

J Clin Ultrasound. 2016 Nov 12;44(9):580-586. doi: 10.1002/jcu.22382. Epub 2016 Jul 22.

PMID:
27447717
19.

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CTS, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw ASH, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y.

Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.

20.

Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.

Braxton DR, Zhang R, Morrissette JD, Loaiza-Bonilla A, Furth EE.

Int J Cancer. 2016 Oct 1;139(7):1546-56. doi: 10.1002/ijc.30196. Epub 2016 Jun 1.

21.

Spontaneous Pancreatitis Caused by Tissue-Specific Gene Ablation of Hhex in Mice.

Ferreira MJ, McKenna LB, Zhang J, Reichert M, Bakir B, Buza EL, Furth EE, Bogue CW, Rustgi AK, Kaestner KH.

Cell Mol Gastroenterol Hepatol. 2015 Sep 1;1(5):550-569. doi: 10.1016/j.jcmgh.2015.06.007.

22.

Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression.

Tarangelo A, Lo N, Teng R, Kim E, Le L, Watson D, Furth EE, Raman P, Ehmer U, Viatour P.

Nat Commun. 2015 Dec 7;6:10028. doi: 10.1038/ncomms10028.

23.

Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.

Choi SM, Furth EE, Zhang PJ.

Appl Immunohistochem Mol Morphol. 2016 Sep;24(8):603-7. doi: 10.1097/PAI.0000000000000244.

PMID:
26469324
24.

Next-generation sequencing and personalized genomic medicine in hepatobiliary malignancies.

Loaiza-Bonilla A, Furth EE, Morrissette JJ.

Hepat Oncol. 2015 Oct;2(4):359-370. doi: 10.2217/hep.15.20. Epub 2015 Nov 11. Review.

25.

Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.

Winter JM, Jiang W, Basturk O, Mino-Kenudson M, Fong ZV, Tan WP, Lavu H, Vollmer CM, Furth EE, Haviland D, Klimstra DS, Jarnagin WR, Lillemoe KD, Yeo CJ, Fernandez-Del Castillo C, Allen PJ.

Ann Surg. 2016 Apr;263(4):793-801. doi: 10.1097/SLA.0000000000001319.

26.

Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management.

Raess PW, Baird-Howell M, Aggarwal R, Williams NN, Furth EE.

Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1020-3. doi: 10.1016/j.soard.2015.01.002. Epub 2015 Jan 9.

PMID:
25868840
27.

Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria.

Hoffman RL, Gates JL, Kochman ML, Ginsberg GG, Ahmad NA, Chandrasekhara V, Furth EE, Vollmer CM, Drebin JA.

J Am Coll Surg. 2015 Jun;220(6):1087-95. doi: 10.1016/j.jamcollsurg.2015.02.013. Epub 2015 Feb 21.

PMID:
25868415
28.

Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.

Gade TP, Hunt SJ, Harrison N, Nadolski GJ, Weber C, Pickup S, Furth EE, Schnall MD, Soulen MC, Celeste Simon M.

J Vasc Interv Radiol. 2015 Aug;26(8):1229-37. doi: 10.1016/j.jvir.2015.02.006. Epub 2015 Apr 8.

29.

Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.

Kaimakliotis P, Riff B, Pourmand K, Chandrasekhara V, Furth EE, Siegelman ES, Drebin J, Vollmer CM, Kochman ML, Ginsberg GG, Ahmad NA.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1808-15. doi: 10.1016/j.cgh.2015.03.017. Epub 2015 Mar 25.

PMID:
25818077
30.

Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry EJ, Vonderheide RH.

Cancer Immunol Res. 2015 Apr;3(4):399-411. doi: 10.1158/2326-6066.CIR-14-0215. Epub 2015 Feb 12.

31.

Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.

Small AJ, Sutherland SE, Hightower JS, Guarner-Argente C, Furth EE, Kochman ML, Forde KA, Bewtra M, Falk GW, Ginsberg GG.

Gastrointest Endosc. 2015 May;81(5):1158-66.e1-4. doi: 10.1016/j.gie.2014.10.029. Epub 2015 Jan 31.

PMID:
25650071
32.

Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma.

Zhang L, Frank R, Furth EE, Ziober AF, LiVolsi VA, Zhang PJ.

Exp Hematol Oncol. 2014 Apr 23;3:12. doi: 10.1186/2162-3619-3-12. eCollection 2014.

33.

Liver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes.

Clayton EF, Malik S, Bonnel A, Mu Y, Olthoff K, Shaked A, Abt PL, Peterman H, Rajender Reddy K, Ottmann S, Furth EE, Levine MH.

Liver Transpl. 2014 Jul;20(7):765-74. doi: 10.1002/lt.23876. Epub 2014 May 26.

34.

Metastatic carcinoma to percutaneous endoscopic gastrostomy tube sites. A report of five cases.

Zhang L, Dean SA, Furth EE, Weinstein GS, LiVolsi VA, Montone KT.

Am J Clin Pathol. 2014 Apr;141(4):510-4. doi: 10.1309/AJCPYL2ZBA7OGZGP.

PMID:
24619751
35.
36.

An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.

Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS.

Cell Rep. 2013 Jun 27;3(6):2088-99. doi: 10.1016/j.celrep.2013.05.036. Epub 2013 Jun 20. Erratum in: Cell Rep. 2013 Jul 25;4(2):403. Rhimm, Andrew D [corrected to Rhim, Andrew D].

37.

Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.

Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG.

Gastrointest Endosc. 2013 Feb;77(2):190-9. doi: 10.1016/j.gie.2012.10.013.

PMID:
23317687
38.

A case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study.

Clayton EF, Furth EE, Ziober A, Xu T, Yao Y, Hwang PG, Bing Z.

Rare Tumors. 2012 Apr 12;4(2):e29. doi: 10.4081/rt.2012.e29. Epub 2012 May 17.

39.

Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model.

Cochran MC, Eisenbrey JR, Soulen MC, Schultz SM, Ouma RO, White SB, Furth EE, Wheatley MA.

Acad Radiol. 2011 Nov;18(11):1341-8. doi: 10.1016/j.acra.2011.06.013.

40.

Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.

Moghanaki D, Mick R, Furth EE, Sohal D, Salmon PM, Behbahani A, Morgans AK, Miller SM, Giantonio BJ, Whittington RW, Haller DG, Rosato EF, Plastaras JP.

JOP. 2011 Sep 9;12(5):438-44.

41.

Clinical features and natural history of hepatocellular adenomas: the impact of obesity.

Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, Olthoff K, Shaked A, Reddy KR.

Aliment Pharmacol Ther. 2011 Sep;34(6):664-74. doi: 10.1111/j.1365-2036.2011.04772.x. Epub 2011 Jul 15.

42.

Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role.

Han Y, Zhang PJ, Chen T, Yum SW, Pasha T, Furth EE.

Gastroenterol Res Pract. 2011;2011:561719. doi: 10.1155/2011/561719. Epub 2011 Jun 30.

43.

Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.

Mayes PA, Dolloff NG, Daniel CJ, Liu JJ, Hart LS, Kuribayashi K, Allen JE, Jee DI, Dorsey JF, Liu YY, Dicker DT, Brown JM, Furth EE, Klein PS, Sears RC, El-Deiry WS.

Cancer Res. 2011 Aug 1;71(15):5265-75. doi: 10.1158/0008-5472.CAN-11-1383. Epub 2011 Jun 6.

44.

Analysis of the human pancreatic stellate cell secreted proteome.

Wehr AY, Furth EE, Sangar V, Blair IA, Yu KH.

Pancreas. 2011 May;40(4):557-66. doi: 10.1097/MPA.0b013e318214efaf.

45.

The nuclear pore complex protein Elys is required for genome stability in mouse intestinal epithelial progenitor cells.

Gao N, Davuluri G, Gong W, Seiler C, Lorent K, Furth EE, Kaestner KH, Pack M.

Gastroenterology. 2011 May;140(5):1547-55.e10. doi: 10.1053/j.gastro.2011.01.048. Epub 2011 Mar 21.

46.

Endoscopic Resection with Ligation Using a Multi-Band Mucosectomy System in Barrett's Esophagus with High-Grade Dysplasia and Intramucosal Carcinoma.

Bhat YM, Furth EE, Brensinger CM, Ginsberg GG.

Therap Adv Gastroenterol. 2009 Nov;2(6):323-30. doi: 10.1177/1756283X09346794.

47.

Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection.

Meriden Z, Forde KA, Pasha TL, Hui JJ, Reddy KR, Furth EE, Wells RG.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):289-96, 296.e1-8. doi: 10.1016/j.cgh.2009.10.034. Epub 2009 Nov 12. Erratum in: Clin Gastroenterol Hepatol. 2010 Aug;8(8):736-7.

48.

Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice.

Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman EG, Lévy E, Verdu EF, Gendron FP, Boudreau F.

PLoS One. 2009 Oct 29;4(10):e7609. doi: 10.1371/journal.pone.0007609.

49.

Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.

Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.

J Gastrointestin Liver Dis. 2009 Jun;18(2):169-76.

50.

Eosinophilic esophagitis: a retrospective review of esophageal biopsy specimens from 1992 to 2004 at an adult academic medical center.

Whitney-Miller CL, Katzka D, Furth EE.

Am J Clin Pathol. 2009 Jun;131(6):788-92. doi: 10.1309/AJCPOMPXJFP7EB4P. Review.

PMID:
19461084

Supplemental Content

Loading ...
Support Center